Need professional-grade analysis? Visit stockanalysis.com
$23.64B
11.44
12,614
2.34%
China Grand Pharmaceutical and Healthcare Holdings Ltd (0512) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD6.76, down 0.59% from the previous close.
Over the past year, 0512 has traded between a low of HKD5.79 and a high of HKD9.83. The stock has gained 14.8% over this period. It is currently 31.2% below its 52-week high.
China Grand Pharmaceutical and Healthcare Holdings Ltd has a market capitalization of $23.64B, with a price-to-earnings ratio of 11.44 and a dividend yield of 2.34%.
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a business collaboration with the Sirtex Group agreement to enable collaboration on research and development of pharmaceutical products. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.
Side-by-side comparison against top Healthcare peers.